Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction. | Genes (Basel) | 2023 | 38002962 | PubTator, text mining | PubMed |
| Enrichment of Deleterious Mutated Genes Involved in Ciliary Function and Histone Modification in Brain Cancer Patient-Derived Xenograft Models. | Biomedicines | 2023 | 38001935 | PubTator, text mining | PubMed |
| Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature. | Discov Oncol | 2023 | 37999824 | PubTator, text mining | PubMed |
| Tight Junction Claudins and Occludin Are Differentially Regulated and Expressed in Genomically Defined Subsets of Colon Cancer. | Curr Issues Mol Biol | 2023 | 37998722 | PubTator, text mining | PubMed |
| Pairwise and higher-order epistatic effects among somatic cancer mutations across oncogenesis. | Math Biosci | 2023 | 37996064 | PubTator, text mining | PubMed |
| PBK correlates with prognosis, immune escape and drug response in LUAD. | Sci Rep | 2023 | 37993518 | PubTator, text mining | PubMed |
| The mutational pattern of homologous recombination repair genes in urothelial carcinoma and its correlation with immunotherapeutic response. | Cancer Med | 2023 | 37986697 | PubTator, text mining | PubMed |
| [Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma]. | Zhongguo Fei Ai Za Zhi | 2023 | 37985153 | PubTator, text mining | PubMed |
| Identification of topoisomerase 2A as a novel bone metastasis-related gene in liver hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37980167 | PubTator, text mining | PubMed |
| Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation. | Invest Ophthalmol Vis Sci | 2023 | 37975847 | PubTator, text mining | PubMed |
| Genetic profile of Chinese patients with small bowel cancer categorized by anatomic location. | BMC Med Genomics | 2023 | 37974218 | PubTator, text mining | PubMed |
Predictive biomarkers of response and survival following immunotherapy with a PD-L1 inhibitor benmelstobart (TQB2450) and antiangiogenic therapy with a VEGFR inhibitor anlotinib for pretreated advanced triple negative breast cancer. | Signal Transduct Target Ther | 2023 | 37973901 | PubTator, text mining | PubMed |
| Whole genome sequencing in high-grade cervical intraepithelial neoplasia patients from different ethnic groups in China. | Medicine (Baltimore) | 2023 | 37960754 | PubTator, text mining | PubMed |
| Developments in Genetics: Better Management of Ovarian Cancer Patients. | Int J Mol Sci | 2023 | 37958970 | PubTator, text mining | PubMed |
| Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma. | Discov Oncol | 2023 | 37957420 | PubTator, text mining | PubMed |
| Increased Gene Expression of C1orf74 Is Associated with Poor Prognosis in Cervical Cancer. | Cells | 2023 | 37947608 | PubTator, text mining | PubMed |
| Leveraging a disulfidptosis/ferroptosis-based signature to predict the prognosis of lung adenocarcinoma. | Cancer Cell Int | 2023 | 37946181 | PubTator, text mining | PubMed |
| Single-cell genomics reveals region-specific developmental trajectories underlying neuronal diversity in the human hypothalamus. | Sci Adv | 2023 | 37939194 | PubTator, text mining | PubMed |
| Pan-cancer Analysis of the Disulfidptosis-related Gene NCKAP1 and Its Prognostic Value for Lung Adenocarcinoma. | J Cancer | 2023 | 37928421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=12